共 127 条
[1]
Ferlay J(2013)Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur J Cancer 49 1374-403
[2]
Steliarova-Foucher E(2013)Improving outcomes in colorectal cancer: where do we go from here? Eur J Cancer 49 2476-85
[3]
Lortet-Tieulent J(2010)Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review Clin Ther 32 437-53
[4]
Rosso S(2010)The value of new chemotherapeutic agents for metastatic colorectal cancer Arch Intern Med 170 537-42
[5]
Coebergh JW(2014)A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer Eur J Cancer 50 40-9
[6]
Comber H(2007)Cost considerations in the treatment of colorectal cancer Pharmacoeconomics 25 537-62
[7]
Van Cutsem E(2007)Costs of cancer care in the USA: a descriptive review Nat Clin Pract Oncol 4 643-56
[8]
Borràs JM(2013)Cost comparisons and methodological heterogeneity in cost-of-illness studies: the example of colorectal cancer Med Care 51 339-50
[9]
Castells A(2013)Economic studies in colorectal cancer: challenges in measuring and comparing costs J Natl Cancer Inst - Monogr 46 62-78
[10]
Ciardiello F(2007)Impact on budget of new drugs for colorectal cancer treatment Med Clin (Barc) 129 134-6